"I think the numbers continue to go up, just because patients are feeling more confident using these drugs, and the indications keep expanding," Egan said
It is not the first time the TGA has issued such a warning, with the viral weight-loss drugs popularity showing no signs of slowing down
Ozempic, for example, is a GLP-1 analog peptide
Less common but significant side effects observed in trials consist of altered skin sensation, severe dermal reactions, and increased susceptibility to allergic reactions
This applies to glucose-metabolizing enzymes (e.g., hexokinase, aldolase, lactate dehydrogenase, phosphofructokinase, and PDH), which increase considerably in activity between the ages of 15 and 30 days (Takagaki, 1974
Over longer trials, semaglutide produced significant, sustained weight reductions in many participants, consistent with findings reported by Infusion Health Telemedicine Clinic